Literature DB >> 11453668

BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells.

Y Nakayama1, S M Weissman, A L Bothwell.   

Abstract

Characterization of genes activated by anti-IgM crosslinking of BL2 cells identified one gene, designated BXMAS1, that is predicted to be a novel cell surface receptor. The time course of activation indicates maximal transcriptional induction after 24 h. The predicted protein contains 977 aa residues, with a cytoplasmic domain containing 2 ITIM motifs. The ectodomain of the protein contains 6 repeats of characteristic 93 aa sequences which we have designated BXMAS1 domains. These domains correspond to 6 out of 8 Ig-like domains in BXMAS1. A search of the human genome revealed 5 additional closely linked homologous genes many of which contain BXMAS1 domains as well. Analysis of expression in cell lines and tissues suggests a general restriction of expression of these genes to B cells. These genes may be involved in B cell development and differentiation in peripheral lymphoid organs and may be useful markers of B cell stages. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453668     DOI: 10.1006/bbrc.2001.5231

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Authors:  Mahdi Shabani; Ali Ahmad Bayat; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Mohammad Hojjat-Farsangi; Cristina Ulivieri; Zahra Amirghofran; Cosima Tatiana Baldari; Fazel Shokri
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

3.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

4.  FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.

Authors:  Tanisha A Jackson; Christopher L Haga; Götz R A Ehrhardt; Randall S Davis; Max D Cooper
Journal:  J Immunol       Date:  2010-11-10       Impact factor: 5.422

5.  Species-specific evolution of the FcR family in endothermic vertebrates.

Authors:  Svetlana A Fayngerts; Alexander M Najakshin; Alexander V Taranin
Journal:  Immunogenetics       Date:  2007-03-14       Impact factor: 3.330

6.  Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma.

Authors:  Zahra Yousefi; Nahid Eskandari
Journal:  Leuk Res Rep       Date:  2019-08-14

7.  Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder.

Authors:  Mollie Capone; John Matthew Bryant; Natalie Sutkowski; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2016-06-17

8.  Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders.

Authors:  Zahra Yousefi; Sedigheh Sharifzadeh; Vali Yar-Ahmadi; Alireza Andalib; Nahid Eskandari
Journal:  Biomark Insights       Date:  2019-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.